IMP3ACTTM PLATFORM

We Don’t Discover Antivirals.
We Design Them.

IMP3ACT is the platform that makes that possible. Decoy’s proprietary peptide conjugate platform pairs AI-enabled design with rapid synthesis and manufacturing, so programs can move toward the clinic faster and the pipeline can grow across many programs at once.

How the platform works

AI-enabled design

Machine learning guides how each candidate is engineered, so the team can explore and refine far faster than older methods allow.

Built to be made at scale

A rapid, repeatable synthesis and manufacturing process is designed to produce candidates quickly and to scale, which also underpins Decoy’s global access commitment.

Engineered across many viruses

The platform is built so one adaptable drug can be designed to act across many viruses rather than one.

A platform that compounds

Decoy does not just move faster. It learns faster. Every candidate sharpens the model through a design, build, test, and learn loop that grows stronger with each program instead of resetting. The chemistry, the linker design, and the data behind it are Decoy’s own, and each program makes the next one better.

Shared Biology Behind Our Scientific Strategy

View Our Approach